Cargando…
FSTL1 promotes bone metastasis by causing immune dysfunction
In spite of significant advances in our understanding of the metastatic process, the relationship between the dissemination of primary neoplasms to the bones and antitumor immunity remains poorly understood. We have recently identified follistatin-like 1 (FSTL1), a soluble protein secreted by snail...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897500/ https://www.ncbi.nlm.nih.gov/pubmed/24482748 http://dx.doi.org/10.4161/onci.26528 |
_version_ | 1782300243637829632 |
---|---|
author | Kudo-Saito, Chie |
author_facet | Kudo-Saito, Chie |
author_sort | Kudo-Saito, Chie |
collection | PubMed |
description | In spite of significant advances in our understanding of the metastatic process, the relationship between the dissemination of primary neoplasms to the bones and antitumor immunity remains poorly understood. We have recently identified follistatin-like 1 (FSTL1), a soluble protein secreted by snail family zinc finger 1 (SNAI1)-expressing cancer cells, as a key determinant of bone metastasis that operates by inducing a systemic state of immune dysfunction. |
format | Online Article Text |
id | pubmed-3897500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-38975002014-01-30 FSTL1 promotes bone metastasis by causing immune dysfunction Kudo-Saito, Chie Oncoimmunology Author's View In spite of significant advances in our understanding of the metastatic process, the relationship between the dissemination of primary neoplasms to the bones and antitumor immunity remains poorly understood. We have recently identified follistatin-like 1 (FSTL1), a soluble protein secreted by snail family zinc finger 1 (SNAI1)-expressing cancer cells, as a key determinant of bone metastasis that operates by inducing a systemic state of immune dysfunction. Landes Bioscience 2013-11-01 2013-10-10 /pmc/articles/PMC3897500/ /pubmed/24482748 http://dx.doi.org/10.4161/onci.26528 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Kudo-Saito, Chie FSTL1 promotes bone metastasis by causing immune dysfunction |
title | FSTL1 promotes bone metastasis by causing immune dysfunction |
title_full | FSTL1 promotes bone metastasis by causing immune dysfunction |
title_fullStr | FSTL1 promotes bone metastasis by causing immune dysfunction |
title_full_unstemmed | FSTL1 promotes bone metastasis by causing immune dysfunction |
title_short | FSTL1 promotes bone metastasis by causing immune dysfunction |
title_sort | fstl1 promotes bone metastasis by causing immune dysfunction |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897500/ https://www.ncbi.nlm.nih.gov/pubmed/24482748 http://dx.doi.org/10.4161/onci.26528 |
work_keys_str_mv | AT kudosaitochie fstl1promotesbonemetastasisbycausingimmunedysfunction |